{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:14:21Z","timestamp":1792782861755,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Sichuan Medical and Health Promotion Association","award":["KY2022SJ0199"],"award-info":[{"award-number":["KY2022SJ0199"]}]},{"name":"Provincial Cadre Healthcare Committee Dissemination Grant","award":["chuanganyan2024-218"],"award-info":[{"award-number":["chuanganyan2024-218"]}]},{"name":"Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital","award":["2022QN49"],"award-info":[{"award-number":["2022QN49"]}],"id":[{"id":"https:\/\/ror.org\/01qh26a66","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100019014","name":"Chengdu Municipal Science and Technology Program","doi-asserted-by":"publisher","award":["2024-YF05-01741-SN,LCMYZHYX-KFKT202302"],"award-info":[{"award-number":["2024-YF05-01741-SN,LCMYZHYX-KFKT202302"]}],"id":[{"id":"10.13039\/501100019014","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Open Project of Sichuan Provincial Key Laboratory for Clinical Immunology Trans-lational Medicine","award":["LCMYZHYX-KFKT202302"],"award-info":[{"award-number":["LCMYZHYX-KFKT202302"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10072-026-09415-4","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:58:42Z","timestamp":1791334722000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel oxidative-inflammatory biomarker for Parkinson\u2019s disease: clinical utility of the uric acid-to-albumin ratio"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5833-910X","authenticated-orcid":false,"given":"Wenbo","family":"Xiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaonan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Shuai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bolin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"9415_CR1","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER et al (2018) Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17:939\u2013953","journal-title":"Lancet Neurol"},{"issue":"9","key":"9415_CR2","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/S1474-4422(19)30195-4","volume":"18","author":"S-Y Lim","year":"2019","unstructured":"Lim S-Y, Tan AH, Ahmad-Annuar A et al (2019) Parkinson\u2019s disease in the Western Pacific Region. Lancet Neurol 18(9):865\u2013879","journal-title":"Lancet Neurol"},{"issue":"5","key":"9415_CR3","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","volume":"68","author":"ER Dorsey","year":"2007","unstructured":"Dorsey ER et al (2007) Projected number of people with Parkinson disease in the world by 2040. Neurology 68(5):384\u2013386","journal-title":"Neurology"},{"issue":"37","key":"9415_CR4","doi-asserted-by":"publisher","first-page":"e30324","DOI":"10.1097\/MD.0000000000030324","volume":"101","author":"S Sun","year":"2022","unstructured":"Sun S, Wen Y, Li Y (2022) Serum albumin, cognitive function, motor impairment, and survival prognosis in Parkinson disease. Med (Baltim) 101(37):e30324","journal-title":"Med (Baltim)"},{"issue":"4","key":"9415_CR5","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection? Lancet Neurol 8(4):382\u2013397","journal-title":"Lancet Neurol"},{"issue":"1","key":"9415_CR6","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41531-024-00785-0","volume":"10","author":"S Shima","year":"2024","unstructured":"Shima S, Mizutani Y, Yoshimoto J et al (2024) Uric acid and alterations of purine recycling disorders in Parkinson\u2019s disease: a cross-sectional study. NPJ Parkinsons Dis 10(1):170","journal-title":"NPJ Parkinsons Dis"},{"key":"9415_CR7","doi-asserted-by":"publisher","first-page":"1322228","DOI":"10.3389\/fneur.2024.1322228","volume":"15","author":"F Li","year":"2024","unstructured":"Li F, Weng G, Zhou H et al (2024) The neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and neutrophil-to-high-density-lipoprotein ratio are correlated with the severity of Parkinson\u2019s disease. Front Neurol 15:1322228","journal-title":"Front Neurol"},{"key":"9415_CR8","doi-asserted-by":"publisher","first-page":"1439803","DOI":"10.3389\/fnut.2024.1439803","volume":"11","author":"H Jia","year":"2024","unstructured":"Jia H, Yin K, Zhao J et al (2024) Association of inflammation\/nutrition-based indicators with Parkinson\u2019s disease and mortality. Front Nutr 11:1439803","journal-title":"Front Nutr"},{"key":"9415_CR9","first-page":"11","volume":"66","author":"N Cakmak","year":"2019","unstructured":"Cakmak N et al (2019) Uric acid to albumin ratio is a novel inflammatory marker with higher prognostic value than C-reactive protein to albumin ratio in non-ST elevation myocardial infarction patients. Clin Biochem 66:11\u201316","journal-title":"Clin Biochem"},{"key":"9415_CR10","first-page":"10","volume":"323","author":"L Kilic","year":"2021","unstructured":"Kilic L et al (2021) Uric acid to albumin ratio predicts new-onset atrial fibrillation and recurrence after catheter ablation in patients with ST-segment elevation myocardial infarction. Int J Cardiol 323:10\u201316","journal-title":"Int J Cardiol"},{"issue":"7","key":"9415_CR11","first-page":"566","volume":"51","author":"N Cakmak","year":"2019","unstructured":"Cakmak N et al (2019) Uric acid to albumin ratio is associated with no-reflow phenomenon in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention. Ann Med 51(7):566\u2013573","journal-title":"Ann Med"},{"issue":"11","key":"9415_CR12","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.21037\/jtd-22-1454","volume":"14","author":"Y Zhou","year":"2022","unstructured":"Zhou Y et al (2022) Preoperative uric acid to albumin ratio predicts lymph node metastasis in non-small cell lung cancer patients undergoing video-assisted thoracoscopic surgery. J Thorac Dis 14(11):4437\u20134445","journal-title":"J Thorac Dis"},{"key":"9415_CR13","first-page":"115545","volume":"336","author":"Y Liu","year":"2024","unstructured":"Liu Y et al (2024) A large-scale study on uric acid-related biomarkers in patients with bipolar disorder. Psychiatry Res 336:115545","journal-title":"Psychiatry Res"},{"issue":"12","key":"9415_CR14","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30(12):1591\u20131601","journal-title":"Mov Disord"},{"issue":"12","key":"9415_CR15","doi-asserted-by":"publisher","first-page":"5739","DOI":"10.1007\/s10072-024-07697-0","volume":"45","author":"J Wu","year":"2024","unstructured":"Wu J, Yang M, Zhang Y et al (2024) Changes in the correlation between substantia nigra hyperechogenicity area and Parkinson\u2019s disease severity at different Hoehn and Yahr stages. Neurol Sci 45(12):5739\u20135747","journal-title":"Neurol Sci"},{"issue":"1","key":"9415_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.14108","volume":"27","author":"R Balestrino","year":"2020","unstructured":"Balestrino R, Schapira AHV (2020) Parkinson disease. Eur J Neurol 27(1):27\u201342","journal-title":"Eur J Neurol"},{"issue":"1","key":"9415_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","volume":"36","author":"DK Simon","year":"2020","unstructured":"Simon DK, Tanner CM, Brundin P (2020) Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology. Clin Geriatr Med 36(1):1\u201312","journal-title":"Clin Geriatr Med"},{"issue":"5","key":"9415_CR18","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.neuint.2012.12.016","volume":"62","author":"JM Taylor","year":"2013","unstructured":"Taylor JM et al (2013) Neuroinflammation and oxidative stress: co-conspirators in the pathology of Parkinson\u2019s disease. Neurochem Int 62(5):621\u2013636","journal-title":"Neurochem Int"},{"issue":"3","key":"9415_CR19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1353-8020(11)70064-5","volume":"18","author":"S Phani","year":"2012","unstructured":"Phani S, Loike JD, Przedborski S (2012) Neurodegeneration and inflammation in Parkinson\u2019s disease. Parkinsonism Relat Disord 18(3):207\u2013209","journal-title":"Parkinsonism Relat Disord"},{"issue":"Pt 6","key":"9415_CR20","first-page":"1263","volume":"31","author":"TB Sherer","year":"2003","unstructured":"Sherer TB et al (2003) Environmental toxins cause mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease. Biochem Soc Trans 31(Pt 6):1263\u20131266","journal-title":"Biochem Soc Trans"},{"issue":"5646","key":"9415_CR21","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1089144","volume":"302","author":"TM Dawson","year":"2003","unstructured":"Dawson TM, Dawson VL (2003) Molecular pathways of neurodegeneration in Parkinson\u2019s disease. Science 302(5646):819\u2013822. https:\/\/doi.org\/10.1126\/science.1089144","journal-title":"Science"},{"issue":"1","key":"9415_CR22","first-page":"151","volume":"20","author":"Z Lin","year":"2025","unstructured":"Lin Z et al (2025) NOX4 exacerbates Parkinson\u2019s disease pathology by promoting neuronal ferroptosis and neuroinflammation. Neural Regen Res 20(1):151\u2013159","journal-title":"Neural Regen Res"},{"issue":"1","key":"9415_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrn2052","volume":"8","author":"ML Block","year":"2007","unstructured":"Block ML et al (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8(1):57\u201369. https:\/\/doi.org\/10.1038\/nrn2052","journal-title":"Nat Rev Neurosci"},{"issue":"Suppl 1","key":"9415_CR24","doi-asserted-by":"publisher","first-page":"S210","DOI":"10.1016\/S1353-8020(11)70065-7","volume":"18","author":"EC Hirsch","year":"2012","unstructured":"Hirsch EC, Vyas S, Hunot S (2012) Neuroinflammation in Parkinson\u2019s disease. Parkinsonism Relat Disord 18(Suppl 1):S210\u2013S212","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"9415_CR25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/mds.28075","volume":"36","author":"EC Hirsch","year":"2021","unstructured":"Hirsch EC, Standaert DG (2021) Ten unsolved questions about neuroinflammation in Parkinson\u2019s disease. Mov Disord 36(1):16\u201324","journal-title":"Mov Disord"},{"issue":"1","key":"9415_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.31887\/DCNS.2017.19.1\/rpal","volume":"19","author":"PC Tiwari","year":"2017","unstructured":"Tiwari PC, Pal R (2017) The potential role of neuroinflammation and transcription factors in Parkinson disease. Dialogues Clin Neurosci 19(1):71\u201380","journal-title":"Dialogues Clin Neurosci"},{"issue":"3","key":"9415_CR27","doi-asserted-by":"publisher","first-page":"e0173731","DOI":"10.1371\/journal.pone.0173731","volume":"12","author":"M Wen","year":"2017","unstructured":"Wen M, Zhou B, Chen YH et al (2017) Serum uric acid levels in patients with Parkinson\u2019s disease: A meta-analysis. PLoS ONE 12(3):e0173731","journal-title":"PLoS ONE"},{"issue":"30","key":"9415_CR28","doi-asserted-by":"publisher","first-page":"e38947","DOI":"10.1097\/MD.0000000000038947","volume":"103","author":"J Zhang","year":"2024","unstructured":"Zhang J, Zeng L, Bu L et al (2024) Association between high uric acid and the risk of Parkinson\u2019s disease: A meta-analysis. Med (Baltim) 103(30):e38947","journal-title":"Med (Baltim)"},{"key":"9415_CR29","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.parkreldis.2018.05.010","volume":"55","author":"X Huang","year":"2018","unstructured":"Huang X, Ng SY, Chia NS et al (2018) Serum uric acid level and its association with motor subtypes and non-motor symptoms in early Parkinson\u2019s disease: PALS study. Parkinsonism Relat Disord 55:50\u201354","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"9415_CR30","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/ene.14070","volume":"27","author":"YS Oh","year":"2020","unstructured":"Oh YS, Kim JS, Yoo SW, Hwang EJ, Lyoo CH, Lee KS (2020) Gender difference in the effect of uric acid on striatal dopamine in early Parkinson\u2019s disease. Eur J Neurol 27(2):258\u2013264","journal-title":"Eur J Neurol"},{"key":"9415_CR31","doi-asserted-by":"publisher","first-page":"1117491","DOI":"10.3389\/fnagi.2023.1117491","volume":"15","author":"YJ Shin","year":"2023","unstructured":"Shin YJ, Kim YJ, Lee JE et al (2023) Uric acid regulates \u03b1-synuclein transmission in Parkinsonian models. Front Aging Neurosci 15:1117491","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"9415_CR32","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10072-016-2738-z","volume":"38","author":"L Wang","year":"2017","unstructured":"Wang L, Hu W, Wang J et al (2017) Impact of serum uric acid, albumin and their interaction on Parkinson\u2019s disease. Neurol Sci 38(2):331\u2013336. https:\/\/doi.org\/10.1007\/s10072-016-2738-z","journal-title":"Neurol Sci"},{"issue":"9","key":"9415_CR33","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1007\/s10072-025-08301-9","volume":"46","author":"M Ding","year":"2025","unstructured":"Ding M, Wang H, Li J, Zhu X (2025) Correlation between Parkinson\u2019s disease subtypes and plasma uric acid\/neutrophil-to-lymphocyte ratio. Neurol Sci 46(9):4415\u20134423","journal-title":"Neurol Sci"},{"issue":"21","key":"9415_CR34","doi-asserted-by":"publisher","first-page":"e40191","DOI":"10.1016\/j.heliyon.2024.e40191","volume":"10","author":"DJ Xu","year":"2024","unstructured":"Xu DJ, Shen YL, Hu MM et al (2024) Association analyses of nutritional markers with Parkinson\u2019s disease and Alzheimer\u2019s disease. Heliyon 10(21):e40191","journal-title":"Heliyon"},{"issue":"12","key":"9415_CR35","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.7150\/ijms.85430","volume":"20","author":"A Qin","year":"2023","unstructured":"Qin A, Yang D, Wang S et al (2023) Uric acid-based ratios for predicting renal failure in Chinese IgA nephropathy patients. Int J Med Sci 20(12):1584\u20131591 Published 2023 Sep 25. https:\/\/doi.org\/10.7150\/ijms.85430","journal-title":"Int J Med Sci"},{"key":"9415_CR36","doi-asserted-by":"publisher","first-page":"1481155","DOI":"10.3389\/fnut.2024.1481155","volume":"11","author":"X Liu","year":"2024","unstructured":"Liu X, Chu A, Ding X (2024) Elevated uric acid to serum albumin ratio: a predictor of short-term outcomes in Chinese heart failure patients. Front Nutr 11:1481155","journal-title":"Front Nutr"},{"issue":"3\u20134","key":"9415_CR37","first-page":"99","volume":"8","author":"E\u00d6 \u00c7akmak","year":"2021","unstructured":"\u00c7akmak E\u00d6, Bayam E, \u00c7elik M et al (2021) Uric acid-to-albumin ratio: A novel marker for the extent of coronary artery disease in patients with non-ST-elevated myocardial infarction. Pulse (Basel) 8(3\u20134):99\u2013107","journal-title":"Pulse (Basel)"},{"issue":"1","key":"9415_CR38","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1186\/s12872-024-04040-5","volume":"24","author":"XJ Zhang","year":"2024","unstructured":"Zhang XJ, Hou AJ, Luan B, Wang CF, Li JJ (2024) Uric acid to albumin ratio as a novel predictor for coronary slow flow phenomenon in patients with chronic coronary syndrome and non-obstructive coronary arteries. BMC Cardiovasc Disord 24(1):358","journal-title":"BMC Cardiovasc Disord"},{"key":"9415_CR39","doi-asserted-by":"crossref","unstructured":"Calabrese V et al (2008 Jul-Aug) Redox regulation of cellular stress response by ferulic acid ethyl ester in human dermal fibroblasts: role of vitagenes.Clinics in Dermatology. 26(4):358\u2013363","DOI":"10.1016\/j.clindermatol.2008.01.005"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09415-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-09415-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09415-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:02:52Z","timestamp":1791378172000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-026-09415-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["9415"],"URL":"https:\/\/doi.org\/10.1007\/s10072-026-09415-4","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"2 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All participants provided written informed consent for the use of their clinical information. The study complied with the Declaration of Helsinki and was approved by the Institutional Review Board of Sichuan Provincial People\u2019 s Hospital (IRB No. 2025160).","order":1,"name":"Ethics","label":"Ethics statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"848"}}